Showing results (151-160 of 213) with videos related to
Sort By:
Pageof 22
Journal of Neurosurgical Sciences|November 24, 2016
Multidisciplinary management of spontaneous spinal infections: is there a correlation between timing, type of treatment and outcome?Alessandro Landi, Alessandro Di Bartolomeo, Nicola Marotta, et al.Neurosurgery|March 29, 2005
Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietinGiovanni Grasso, Alessandra Sfacteria, Marcello Passalacqua, et al.Neurosurgical Focus|August 1, 2023
MR-guided focused ultrasound-induced blood-brain barrier opening for brain metastasis: a reviewGiovanni Grasso, Fabio Torregrossa, Manfredi Noto, et al.Surgical Neurology International|May 19, 2015
Autologous fibrin sealant (Vivostat(®)) in the neurosurgical practice: Part I: Intracranial surgical procedureFrancesca Graziano, Francesco Certo, Luigi Basile, et al.World Neurosurgery|May 20, 2020
Resting-State Functional Connectome in Patients with Brain Tumors Before and After Surgical ResectionGianvincenzo Sparacia, Giuseppe Parla, Vincenzina Lo Re, et al.World Journal of Surgical Oncology|January 16, 2010
Intramedullary non-specific inflammatory lesion of thoracic spine: a case reportAlessandro Landi, Valerio Di Norcia, Demo Eugenio Dugoni, et al.Journal of Neurological Surgery. Part A, Central European Neurosurgery|February 4, 2021
Outcome Features Analysis in Intramedullary Tumors of the Cervicomedullary Junction: A Surgical SeriesLeonardo Tariciotti, Giacoma Maria Floriana Brunetto, Alessandro Landi, et al.Sensors (Basel, Switzerland)|February 28, 2023
Sol-Gel Dipping Devices for H2S VisualizationMaria Strianese, Giovanni Ferrara, Viktoriia Vykhovanets, et al.Pain|August 26, 2004
Estrogen and mu-opioid receptor antagonists counteract the 17 beta-estradiol-induced licking increase and interferon-gamma reduction occurring during the formalin test in male ratsIlaria Ceccarelli, Paolo Fiorenzani, Giovanni Grasso, et al.Current Drug Targets|October 29, 2009
Down with the erythropoietin. Long live the erythropoietin!Michele Buemi, Antonio Lacquaniti, Davide Bolignano, et al.Pageof 22